INR 222.0
(2.59%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 39.34 Million | -44.13 Million | 16.87 Million | 28.99 Million | 32.35 Million | 58.26 Million |
Net Income | 12.68 Million | -68.04 Million | -6.64 Million | 171.43 Million | -61.23 Million | -118.17 Million |
Depreciation & Amortization | 21.57 Million | 39.11 Million | 53.53 Million | 49.3 Million | 58.77 Million | 88.42 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 48.22 Million | -1.66 Million | -17.59 Million | 45.49 Million | 21.18 Million | 31.13 Million |
Other non-cash items | 4.38 Million | -13.54 Million | -12.41 Million | -237.24 Million | 13.63 Million | 56.88 Million |
Investing Cash Flow | -51.6 Million | 29.08 Million | 21.64 Million | 92.69 Million | 8.89 Million | 9.59 Million |
Investments in PPE | -8.13 Million | -11.24 Million | -11.74 Million | -6.78 Million | -7.18 Million | -6.36 Million |
Acquisitions | 8.88 Million | 20.52 Million | 999 Thousand | 122.78 Million | 4.51 Million | 1.91 Million |
Investment purchases | -83.22 Million | -74.39 Million | -100.49 Million | -291.5 Million | - | 2.14 Million |
Sales/Maturities of investments | 30.86 Million | 91.3 Million | 127.5 Million | 129.2 Million | - | 6.85 Million |
Other Investing Activities | -52.22 Million | 2.89 Million | 5.38 Million | 139 Million | 11.56 Million | 5.03 Million |
Financing Cash Flow | -5.94 Million | -5.97 Million | -1.67 Million | -99.41 Million | -45.09 Million | -68.34 Million |
Debt repayment | - | - | - | -90.86 Million | -30.97 Million | -47.62 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -6.37 Million | - | - | -8.54 Million | -14.11 Million | -20.71 Million |
Accounts receivables | 12.5 Million | -7.52 Million | 16.42 Million | 139.25 Million | 25.78 Million | -12.68 Million |
Accounts payables | -27.88 Million | -431 Thousand | -5.58 Million | -144.33 Million | 12.96 Million | 19.34 Million |
Inventory | 11 Million | 61.95 Million | -61.73 Million | 49.44 Million | -2.48 Million | 9.84 Million |
Other working capital | 52.6 Million | -55.66 Million | 33.28 Million | 1.12 Million | -15.07 Million | 14.64 Million |
Cash at beginning of period | 40.63 Million | 61.52 Million | 24.67 Million | 2.39 Million | 10.03 Million | 10.54 Million |
Cash at end of period | 103.43 Million | 40.48 Million | 61.52 Million | 24.67 Million | 6.19 Million | 10.03 Million |
Capital Expenditure | -8.13 Million | -11.24 Million | -11.74 Million | -6.78 Million | -7.18 Million | -6.36 Million |
Effect of forex changes on cash | - | - | - | - | - | -30 Thousand |
Net cash flow / Change in cash | 62.79 Million | -21.03 Million | 36.84 Million | 22.28 Million | -3.84 Million | -515 Thousand |
Free Cash Flow | 31.2 Million | -55.38 Million | 5.12 Million | 22.2 Million | 25.16 Million | 51.9 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 12.68 Million | 11.79 Million | -2.11 Million | -6.11 Million | -68.04 Million | -3 Million |
Depreciation & Amortization | 21.57 Million | 4.67 Million | 4.92 Million | 5.15 Million | 39.11 Million | 9.56 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 48.22 Million | - | - | - | -1.66 Million | - |
Other non-cash items | 4.38 Million | -7.11 Million | -4.92 Million | -5.15 Million | -13.54 Million | -9.56 Million |
Investing Cash Flow | -51.6 Million | - | - | - | 29.08 Million | - |
Investments in PPE | -8.13 Million | - | - | - | -11.24 Million | - |
Acquisitions | 8.88 Million | - | - | - | 20.52 Million | - |
Investment purchases | -83.22 Million | - | - | - | -74.39 Million | - |
Sales/Maturities of investments | 30.86 Million | - | - | - | 91.3 Million | - |
Other Investing Activities | -52.22 Million | - | - | - | 2.89 Million | - |
Financing Cash Flow | -5.94 Million | - | - | - | -5.97 Million | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | 12.5 Million | - | - | - | -7.52 Million | - |
Accounts payables | -27.88 Million | - | - | - | -431 Thousand | - |
Inventory | 11 Million | - | - | - | 61.95 Million | - |
Other working capital | 52.6 Million | - | - | - | -55.66 Million | - |
Cash at beginning of period | 40.63 Million | 90.57 Million | 92.69 Million | 40.63 Million | 61.52 Million | 43.63 Million |
Cash at end of period | 103.43 Million | 99.93 Million | 90.57 Million | -6.11 Million | 40.48 Million | 40.63 Million |
Capital Expenditure | -8.13 Million | - | - | - | -11.24 Million | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 62.79 Million | 9.35 Million | -2.11 Million | -46.75 Million | -21.03 Million | -3 Million |
Free Cash Flow | 31.2 Million | 9.35 Million | -2.11 Million | -6.11 Million | -55.38 Million | -3 Million |
SUNPHARMA
AMNPLST
VSTL
ALORD
SWSDF
ROSSARI